Skip to main content

Hyaluronan-enriched transfer medium improves outcome in patients with multiple embryo transfer failures

Abstract

Purpose

To ascertain whether the use of hyaluronan-enriched transfer medium (HETM) improves pregnancy and implantation rates among embryo transfer patients with a history of multiple implantation failures.

Methods

Patients (n = 314) under the age of 40 and with a history of multiple unsuccessful embryo transfers were enrolled. There were three groups of patients: those undergoing fresh embryo transfer (fresh ET [n = 111]), those undergoing vitrified-warmed ET in the natural cycle (WET-N [n = 101]) and those undergoing WET in a hormone replacement cycle (WET-H [n = 102]). On the day of ET, patients were randomized to HETM (0.5 mg/ml hyaluronan) or control medium containing no hyaluronan. Only patients with good quality embryos on day 3 were included.

Results

For all three patients groups (fresh ET, WET-N and WET-H) pregnancy rates (37.5 %, 31.4 % and 41.2 %, respectively) were significantly higher when using HETM compared with control medium (10.9 %, 10.0 % and 15.7 %, respectively; p < 0.05), and implantation rates when using HETM were also significantly higher compared with control medium (p < 0.05). Miscarriage rates were similar in both groups.

Conclusion

HETM significantly increased pregnancy and implantation rates among embryo transfer patients with a history of multiple unsuccessful implantations–regardless of method used to prepare the endometrium.

This is a preview of subscription content, access via your institution.

References

  1. Salustri A, Camaioni A, Di Giacomo M, Fulop C, Hascall VC. Hyaluronan and proteoglycans in ovarian follicles. Hum Reprod Update. 1999;5:293–301.

    PubMed  Article  CAS  Google Scholar 

  2. Carson DD, Dutt A, Tang JP. Glycoconjugate synthesis during early pregnancy: hyaluronate synthesis and function. Dev Biol. 1987;120:228–35.

    PubMed  Article  CAS  Google Scholar 

  3. Campbell S, Swann HR, Aplin JD, Seif MW, Kimber SJ, Elstein M. CD44 is expressed throughout pre-implantation human emnryo development. Hum Reprod. 1995;10:425–30.

    PubMed  CAS  Google Scholar 

  4. Afify AM, Crais S, Paulino AF. Temporal variation in the distribution if hyaluronic acid, CD44s, and CD44v6 in the human endometrium across the menstrual cycle. Mol Morphol. 2006;14:328–33.

    CAS  Google Scholar 

  5. Urman B, Yakin K, Ata B, Isikawa, Balaban B. Effects of hyaluronan-enriched transfer medium on implantation and pregnancy rates after day 3 and day 5 embryo transfer: a prospective randomized study. Fertil Steril. 2008;90:604–12.

    PubMed  Article  Google Scholar 

  6. Valojerdi MR, Karimian L, Yazdi PE, Gilani MA, Madani T, Baghestani AR. Efficacy of a human embryo transfer medium: a prospective, randomized clinical trial study. J Assist Reprod Genet. 2006;23:207–12.

    PubMed  Article  Google Scholar 

  7. Loutradi KE, Prassas I, Bili E, Sanopoulou T, Bontis I, Tarlatzis BC. Evaluation of a transfer medium containing high concentration of hyaluronan in human in vitro fertilization. Fertil Steril. 2007;87:48–52.

    PubMed  Article  CAS  Google Scholar 

  8. Nakagawa K, Nishi Y, Sugiyama R, Jyuen H, Takahashi C, Ojiro Y, Kuribayashi Y, Sugiyama R. A programmed schedule of oocyte retrieval using mild ovarian stimulation (clomiphene citrate and recombinant follicular stimulating hormone). Reprod Med Biol. doi:10.1007/s12522-011-0110-9.

  9. Nakagawa K, Ohgi S, Kojima R, Ito M, Horikawa T, Irahara M, Saito H. Reduction of perifollicular arterial blood flow resistance after hCG administration is a good indicator of the recovery of mature oocytes in ART treatment. J Assist Reprod Genet. 2006;23:433–8.

    PubMed  Article  Google Scholar 

  10. Nakagawa K, Yamano S, Moride N, Yamashita M, Yoshizawa M, Aono T. Effect of activation with Ca ionophore A23187 and puromycin on the development of human oocytes that failed to fertilize after intracytoplasmic sperm injection. Fertil Steril. 2001;76:148–52.

    PubMed  Article  CAS  Google Scholar 

  11. Veeck LL. Atlas of the human oocyte and early conceptus Vol. 2, Williams & Wilkins Co; 1991.

  12. Nakagawa K, Nishi Y, Sugiyama R, Kuribayashi Y, Sugiyama R, Inoue M. Elective single cleavage-stage embryo transfer need not result in lower pregnancy rates compared to double cleavage-stage embryo transfer. J Obstet Gynecol Res. 2010;36:777–82.

    Article  Google Scholar 

  13. Sugiyama R, Nakagawa K, Shirai A, Sugiyama R, Nishi Y, Kuribayashi Y, Inoue M. Clinical outcomes resulting from the transfer of vitrified human embryos using a new device for cryopreservation (plastic blade). J Assist Reprod Genet. 2010;27:161–7.

    PubMed  Article  Google Scholar 

  14. Herrler A, von Rango U, Beier HM. Embryo-maternal signaling: how the embryo starts talking to its mother to accomplish implantation. Reprod Biomed Online. 2003;6:244–56.

    PubMed  Article  CAS  Google Scholar 

  15. Minas V, Loutradis D, Makrigiannakis A. Factors controlling blastocyst implantation. Reprod Biomed Online. 2005;10:205–16.

    PubMed  Article  CAS  Google Scholar 

  16. Gardner DK, Rodriegez-Martinez H, Lane M. Fetal development after transfer is increased by replacing protein with the glycosaminoglycan hyaluronan for mouse embryo culture and transfer. Hum Reprod. 1999;14:2575–80.

    PubMed  Article  CAS  Google Scholar 

  17. Mansour RT, Aboulghar MA. Optimizing the embryo transfer technique. Hum Reprod. 2002;17:1149–53.

    PubMed  Article  CAS  Google Scholar 

  18. Ropponen K, Tammi M, Parkkinen J, Eskelinen M, Tammi R, Lipponen P, et al. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res. 1998;58:342–7.

    PubMed  CAS  Google Scholar 

  19. Anttila MA, Tammi RH, Tammi MI, Syrjanen KJ, Saarikoski SV, Kosma VM. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res. 2000;60:150–5.

    PubMed  CAS  Google Scholar 

  20. Bontekoe S, Blake D, Heineman MJ, Williams EC, Johnson N. Adherence compounds in embryo transfer media for assisted reproductive technologies. Cochrane Detabase Syst Rev. 2010;(7):CD007421.

  21. Friedler S, Schachter M, Strassburger D, Esther K, Ron EI-R, Raziel A. A randomized clinical trial comparing recombinant hyaluronan/recombinant albumin versus human tubal fluid for cleavage stage embryo transfer in patients with multiple IVF-embryo transfer failure. Hum Reprod. 2007;22:2444–8.

    PubMed  Article  CAS  Google Scholar 

  22. Hambiliki F, Ljunger E, Karlström PO, Stavreus-Evers A. Hyaluronan-enriched transfer medium in cleavage-stage frozen-thawed embryo transfers increase implantation rate without improvement of delivery rate. Fertil Steril. 2009;94:1669–73.

    PubMed  Article  Google Scholar 

  23. Magi MC, Gianaroli L, Ferraretti AP, Lappi M, Ruberti A, Farfalli V. Embryo morphology and development are dependent on the chromosomal complement. Fertil Steril. 2007;87:534–41.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Koji Nakagawa.

Additional information

Capsule

HETM significantly increased pregnancy and implantation rates among patients with a history of multiple unsuccessful implantations–regardless of method used to prepare the endometrium.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Nakagawa, K., Takahashi, C., Nishi, Y. et al. Hyaluronan-enriched transfer medium improves outcome in patients with multiple embryo transfer failures. J Assist Reprod Genet 29, 679–685 (2012). https://doi.org/10.1007/s10815-012-9758-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-012-9758-2

Keywords

  • Hyaluronan
  • Vitrified-warmed embryo
  • Multiple embryo transfer failures
  • Implantation
  • Natural cycle
  • Hormone replacement cycle